OVERVIEW
Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Glucagon Like Peptide-1 (GLP-1) Agonists Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Glucagon Like Peptide-1 (GLP-1) Agonists industry, both domestically and internationally, with a focus on the following key areas:
1.An overview and assessment of the current development status and emerging trends in the Glucagon Like Peptide-1 (GLP-1) Agonists industry across global and Chinese markets.
2.Estimation of the overall market size of the Glucagon Like Peptide-1 (GLP-1) Agonists industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Glucagon Like Peptide-1 (GLP-1) Agonists industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.
This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.
The study provides a detailed examination of the production, consumption, import, and export dynamics of the Glucagon Like Peptide-1 (GLP-1) Agonists market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.
Furthermore, the report delivers a thorough analysis of segmented growth within the Glucagon Like Peptide-1 (GLP-1) Agonists product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.
In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Glucagon Like Peptide-1 (GLP-1) Agonists market.
1. Key Global Players in the Glucagon Like Peptide-1 (GLP-1) Agonists Industry:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
2.Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, Segmented by Product Type:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, Segmented by Application
Hospital
Pharmacy
Other
4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)
I. Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview:
1.1 Product Definition and Statistical Scope
1.2 On the basis of different product types, Glucagon Like Peptide-1 (GLP-1) Agonists can be mainly categorized as follows:
Global Growth Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type 2020 VS 2024 VS 2031
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
1.3 From different applications, Glucagon Like Peptide-1 (GLP-1) Agonists mainly includes the following:
Global Different Applications Glucagon Like Peptide-1 (GLP-1) Agonists Growth Trend 2020 VS 2024 VS 2031
Hospital
Pharmacy
Other
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Development Status and Future Trends (2020-2031)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2020-2031)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2020-2031)
II. Global Market Major Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Analysis:
2.1 Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share
Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2020-2025)
Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share (2020-2025)
2.2 Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share
Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2020-2025)
Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share (2020-2025)
Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Ranking by 2024
2.3 Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Price (2020-2025)
2.4 Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Headquarter and Origin Distribution
2.5 Global Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Establishment Date and Glucagon Like Peptide-1 (GLP-1) Agonists Commercialization Date
2.6 Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type and Application
2.7 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Concentration, Competition Analysis
Glucagon Like Peptide-1 (GLP-1) Agonists Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.
2.8 New Investments and Market M&A Activities
III. Profiles of the following key players:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
1. Basic Information, Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base, Headquarters, Competitors and Market Position.
2. Glucagon Like Peptide-1 (GLP-1) Agonists Product Specifications, Parameters, and Market Applications .
3. Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.
IV. Analysis of Different Product Types of Glucagon Like Peptide-1 (GLP-1) Agonists:
4.1 Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type (2020-2025)
Global Market Sales Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Different Product Types (2026-2031)
4.2 Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Size by Product Type (2020-2031)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type (2026-2031)
4.3 Global Market Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type (2020-2031)
V. Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists for Different Applications
5.1 Global Market Sales of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2020-2031)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application (2020-2025)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2026-2031)
5.2 Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Size and Market Share by Application (2020-2025)
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Size Forecast by Application (2026-2031)
5.3 Global Market Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 Development Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists Industry - Development Trend
6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Development Analysis - Manufacturer Barriers
6.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Development Analysis - Driving Factors
6.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Development Analysis - Restraints
6.5 SWOT Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists Global Companies
6.6 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning
VII. Industry Supply Chain Analysis
7.1 Industry Chain Introduction of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis - Upstream
7.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis - Midstream
7.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis - Downstream
7.5 Procurement Mode of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
7.6 Production Mode of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
7.7 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Sales Model and Sales Channels
VIII. Global Local Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production Analysis
8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Supply and Demand Status and Forecast (2020-2031)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Market Demand and Development Trend (2020-2031)
8.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export Analysis
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Main Import Sources
Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Main Export Destinations
IX. Research Findings and Conclusion
X. Appendix
10.1 Research Methodology
10.2 Data Sources
Secondary Information Sources
Primary Information Sources
10.3 Data Interactive Validation
10.4 Disclaimer”
Table of Contents
Table : Growth Trends in Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
Table:Development Trend of Glucagon Like Peptide-1 (GLP-1) Agonists
Table:Global Major Regions Production of Glucagon Like Peptide-1 (GLP-1) Agonists
Table:Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share
Table:Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Production Capacity
Table:Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share, Price
Table: Global Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Ranking by 2025
Table: China Market Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Ranking by 2025
Table: Global Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Production Distribution and Commercialization Date
Table:Global Major Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type List
Table: Global Key Manufacturers Market Position of Glucagon Like Peptide-1 (GLP-1) Agonists in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue
Table: Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share
Table: Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share
Table: Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume
Table: Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Table : Global Major Regions Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share
Table : The following companies:
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base, Sales Area, Competitors and Market Position
Glucagon Like Peptide-1 (GLP-1) Agonists Product Specifications, Parameters and Market Applications
Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News
Table: Global Sales of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Sales Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Sales Market Share Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Revenue of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Product Type
Table: Global Revenue Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Revenue Market Share Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Table: Global Sales of Glucagon Like Peptide-1 (GLP-1) Agonists by Application
Table: Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application
Table: Global Sales Forecast of Glucagon Like Peptide-1 (GLP-1) Agonists by Application
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Application
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Application
Table: Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Application
Table: Global Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Application
Table: List of Glucagon Like Peptide-1 (GLP-1) Agonists Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table: Glucagon Like Peptide-1 (GLP-1) Agonists Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Glucagon Like Peptide-1 (GLP-1) Agonists Industry
Table: Risks Faced by Glucagon Like Peptide-1 (GLP-1) Agonists Industry Development
Table: Glucagon Like Peptide-1 (GLP-1) Agonists Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Capacity Utilization and Development Trend
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production, Demand and Development Trend
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Market Share by Major Regions
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Capacity Utilization and Development Trend
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Market Demand and Development Trend
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Sales and Growth Rate.
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size
Figure Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate
Figure Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Price Trend
Figure Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share of Major Manufacturers in 2025
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share of Key Manufacturers in China Market in 2025
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Manufacturers
Figure 2025 Global Glucagon Like Peptide-1 (GLP-1) Agonists First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue Market Share by Major Regions
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate
Figure Europe Market Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate
Figure Europe Market Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate
Figure China Market Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate in Japan Market
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Product Type
Figure Global Price Trend of Glucagon Like Peptide-1 (GLP-1) Agonists by Application
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Chinese Companies SWOT Analysis
Figure Key Interview Objectives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-04-19 12:16:58 
Pages: 104 
Tables: 124 
